Trials / Completed
CompletedNCT06671431
Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma
Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma: a Retrospective Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 578 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Recent studies addressing the role of adjuvant chemotherapy in cholangiocarcinoma (CCA) have been published; however, there are challenges in generalizing the findings due to different prognostic characteristics depending on tumor location and resectability. Therefore, the aim of this study was to investigate the role of AC in distal cholangiocarcinoma, a common tumor subtype of CCA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adjuvant chemotherapy | Adjuvant chemotherapy with or without radiotherapy |
Timeline
- Start date
- 2000-01-01
- Primary completion
- 2021-12-31
- Completion
- 2024-10-01
- First posted
- 2024-11-04
- Last updated
- 2024-11-04
Source: ClinicalTrials.gov record NCT06671431. Inclusion in this directory is not an endorsement.